Novartis Pharmaceuticals Corporation

Deferoxamine Mesylate

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  deferoxamine mesilate;N'-{5-[acetyl(hydroxy)amino]pentyl}-N-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-N-hydroxybutanediamide methanesulfonate (1:1);N'-{5-[acetyl(hydroxy)amino]pentyl}-N-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-N-hydroxybutanediamide methanesulfonate (1:2);

• CAS NO :

  138-14-7

• EC NO :

  205-314-3

• Molecular Formula :

  C₂₇H₅₆N₆O₁₄S₂

• Molecular Weight :

  752.8953

• Main Specifications :

• InChI :

  InChI=1/C25H48N6O8.2CH4O3S/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;2*1-5(2,3)4/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);2*1H3,(H,2,3,4)

• Molecular Structure :